Výsledky vyhledávání - "ETOPOSIDE/therapeutic use"

Akademický článek

Efficacy and toxicity of mitoxantrone and oral etoposide in the treatment of hormone-refractory prostate cancer: pilot study

Autor: Rafael Kaliks, Camila Guerra, Auro Del Giglio

Publikováno v: Einstein (São Paulo), Vol 8, Iss 3, Pp 336-338 (2010)

ABSTRACT Objective: To evaluate the efficacy and toxicity of the association of mitoxantrone and oral etoposide. Methods: Twelve consecutive patients with metastatic hormone-refractory prostate cancer were treated with mitoxantrone and oral etoposide

Externí odkaz: https://doaj.org/article/529b6acdf51d42fbbd172c5cb4a3f94a

Zobrazit plný text záznamu

Targeting DNA Damage in SCLC

Autor: Fabio Gomes, Fiona H Blackhall, Kristopher K. Frese, Katie Baker, Martin Forster, Maximilian W Schenk, Alice Lallo, Victoria Foy, Caroline Dive

Publikováno v: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Foy, V, Schenk, M, Baker, K, Gomes, F, Lallo, A, Frese, K, Forster, M, Dive, C & Blackhall, F 2017, ' Targeting DNA damage in SCLC ', Lung Cancer, vol. 114, 11, pp. 12-22 . https://doi.org/10.1016/j.lungcan.2017.10.006

SCLC accounts for 15% of lung cancer worldwide. Characterised by early dissemination and rapid development of chemo-resistant disease, less than 5% of patients survive 5 years. Despite 3 decades of clinical trials there has been no change to the stan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2d985075e4d708fa0a6f83fb0013005
https://hdl.handle.net/10400.17/2823

Zobrazit plný text záznamu

Severe Muscle Weakness due to Hypokalemia as a Manifestation of Small-Cell Carcinoma

Autor: Katerina Panteli, Moses Elisaf, Athanasios Konstantinidis, Stavros H. Constantopoulos

Publikováno v: Respiration. 66:269-272

We describe the case of a 56-year-old man with severe muscle weakness due to heavy hypokalemia (serum potassium 1.44 mmol/l) associated with inappropriate kaliuria and alkalemia. Subsequent investigation revealed the presence of ectopic ACTH hypersec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed83c8480502b916f52ab7112413474f
https://doi.org/10.1159/000029372

Zobrazit plný text záznamu

Treatment of a Human Renal Cell Carcinoma in Nude Mice with Recombinant Human Tumor Necrosis Factor Alpha and Etoposide

Autor: B. Maurer-Schultze, G. Hofmockel, D. Heimbach, Ioannis D. Bassukas, M. P. Wirth

Publikováno v: Journal of Urology. 150:1974-1979

The effect of treating a human renal cell adenocarcinoma xenografted into Balb/c-nu/nu (nude) mice with recombinant human tumor necrosis factor alpha (TNF alpha) and the cytostatic agent etoposide (ETP) as monotherapy or combination has been studied.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ffd199fc0ca34c167dbe401ef4806e
https://doi.org/10.1016/s0022-5347(17)35949-9

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy and toxicity of mitoxantrone and oral etoposide in the treatment of hormone-refractory prostate cancer: pilot study

Autor: Auro Del Giglio, Camila Guerra, Rafael Aliosha Kaliks

Publikováno v: einstein (São Paulo) v.8 n.3 2010
Einstein (São Paulo)
Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE
Einstein (São Paulo), Vol 8, Iss 3, Pp 336-338 (2010)

Objetivo: Avaliar a eficacia e toxicidade da associacao mitoxantrona e etoposideo oral. Metodos: Doze pacientes consecutivos com câncer de prostata metastatico e refratario a tratamento hormonal foram tratados com mitoxantrona e etoposideo oral. Ava

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ff38cd372e1ca99e57be92581a2f39e
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082010000300336

Zobrazit plný text záznamu

Hochdosischemotherapie mit autologem Stammzellsupport für Patienten mit AFP-produzierendem Germinom im Rezidiv

Autor: Ziske, C, Mezger, J, Jiménez, C, Kleinschmidt, R, Pels, H, Schlegel, U, Schmidt-Wolf, IGH

Publikováno v: German Medical Science : GMS e-journal
GMS German Medical Science, Vol 1, p Doc03 (2003)
German Medical Science; VOL: 1; DOC03 /20030701/

We report of a 34-year old man with second intracranial relapse of a suprasellar germinoma. Despite of extensive pretreatment with radiation and conventional chemotherapy relapse occurred and was treated with sequential high-dose chemotherapy followe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::32142c8c376b8fda087b9ee128fa9d40
http://europepmc.org/articles/PMC2703232

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání